Skip to main content
Premium Trial:

Request an Annual Quote

Commercialization, American-Style

Universities in Russia are starting to adopt American tactics, like business incubators and spin-off companies, when it comes to commercializing their research, says The Chronicle of Higher Education's Goldie Blumenstyk. The project, called Enhancing University Research and Entrepreneurial Capacity — Eureca, for short — is an attempt to build stronger ties between Russian academia and industry, and will consist of several Russian research universities working with teams from four American institutions "to learn the nuts and bolts of technology transfer and other approaches for collaborating with industry," Blumenstyk says. Last year, Russia adopted a law allowing researchers to commercialize their own findings, but they lack the expertise needed to start, she adds.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.